HMD — Hera Med Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- AU$6.75m
- AU$5.91m
- $0.40m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.145 | 0.04 | 0.087 | 0.219 | 0.403 |
Cost of Revenue | |||||
Gross Profit | 0.034 | 0.008 | 0.044 | 0.141 | 0.242 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.31 | 3.4 | 4.12 | 3.4 | 4.84 |
Operating Profit | -3.16 | -3.36 | -4.04 | -3.18 | -4.43 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.13 | -3.36 | -5.71 | -4.88 | -4.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.13 | -3.36 | -5.71 | -4.88 | -4.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.13 | -3.36 | -5.71 | -4.88 | -4.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.13 | -3.36 | -5.71 | -4.88 | -4.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.034 | -0.026 | -0.031 | -0.022 | -0.017 |